Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 517504, 12 pages
http://dx.doi.org/10.1155/2014/517504
Review Article

Genetic Polymorphisms Involved in Folate Metabolism and Maternal Risk for Down Syndrome: A Meta-Analysis

1Unidade de Pesquisa em Genética e Biologia Molecular (UPGEM), Faculdade de Medicina de São José do Rio Preto (FAMERP), Avenida Brigadeiro Faria Lima No. 5416, Bloco U-6, 15090-000 São José do Rio Preto, SP, Brazil
2Núcleo Transdisciplinar para Estudo do Caos e da Complexidade (NUTECC), Faculdade de Medicina de São José do Rio Preto (FAMERP), 15090-000 São José do Rio Preto, SP, Brazil

Received 24 August 2014; Revised 18 October 2014; Accepted 20 October 2014; Published 4 December 2014

Academic Editor: Francisco Blanco-Vaca

Copyright © 2014 Daniella Balduino Victorino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Antonarakis, R. Lyle, E. T. Dermitzakis, A. Reymond, and S. Deutsch, “Chromosome 21 and down syndrome: from genomics to pathophysiology,” Nature Reviews Genetics, vol. 5, no. 10, pp. 725–738, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Hassold, M. Abruzzo, K. Adkins et al., “Human aneuploidy: incidence, origin, and etiology,” Environmental and Molecular Mutagenesis, vol. 28, pp. 167–175, 1996. View at Google Scholar
  3. K. L. Jones, Smith's Recognizable Patterns of Human Malformation, Elsevier Saunders, Philadelphia, Pa, USA, 6th edition, 2007.
  4. S. B. Freeman, E. G. Allen, C. L. Oxford-Wright et al., “The National Down Syndrome Project: design and implementation,” Public Health Reports, vol. 122, no. 1, pp. 62–72, 2007. View at Google Scholar · View at Scopus
  5. G. Cocchi, S. Gualdi, C. Bower et al., “International trends of Down syndrome 1993–2004: births in relation to maternal age and terminations of pregnancies,” Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 88, no. 6, pp. 474–479, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Irving, A. Basu, S. Richmond, J. Burn, and C. Wren, “Twenty-year trends in prevalence and survival of Down syndrome,” European Journal of Human Genetics, vol. 16, no. 11, pp. 1336–1340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. K. Melve, R. T. Lie, R. Skjaerven et al., “Registration of down syndrome in the medical birth registry of norway: validity and time trends,” Acta Obstetricia et Gynecologica Scandinavica, vol. 87, no. 8, pp. 824–830, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. E. G. Allen, S. B. Freeman, C. Druschel et al., “Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects,” Human Genetics, vol. 125, no. 1, pp. 41–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Migliore, F. Migheli, and F. Coppedè, “Susceptibility to aneuploidy in young mothers of Down syndrome children,” TheScientificWorldJournal, vol. 9, pp. 1052–1060, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. K. Eskes, “Abnormal folate metabolism in mothers with Down syndrome offspring: review of the literature,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 124, no. 2, pp. 130–133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. J. James, M. Pogribna, I. P. Pogribny et al., “Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome,” The American Journal of Clinical Nutrition, vol. 70, no. 4, pp. 495–501, 1999. View at Google Scholar · View at Scopus
  12. W. D. King, V. Ho, L. Dodds, S. L. Perkins, R. I. Casson, and T. E. Massey, “Relationships among biomarkers of one-carbon metabolism,” Molecular Biology Reports, vol. 39, no. 7, pp. 7805–7812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. R. Wolthers and N. S. Scrutton, “Protein interactions in the human methionine synthase-methionine synthase reductase complex and implications for the mechanism of enzyme reactivation,” Biochemistry, vol. 46, no. 23, pp. 6696–6709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Olteanu, T. Munson, and R. Banerjee, “Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase,” Biochemistry, vol. 41, no. 45, pp. 13378–13385, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Seetharam, “Receptor-mediated endocytosis of cobalamin (vitamin B12),” Annual Review of Nutrition, vol. 19, pp. 173–195, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. Kraus, “Biochemistry and molecular genetics of cystathionine β-synthase deficiency,” European Journal of Pediatrics, Supplement, vol. 157, pp. S50–S53, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. D. W. Hum, A. W. Bell, R. Rozen, and R. E. MacKenzie, “Primary structure of a human trifunctional enzyme. Isolation of a cDNA encoding methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase,” The Journal of Biological Chemistry, vol. 263, no. 31, pp. 15946–15950, 1988. View at Google Scholar · View at Scopus
  18. C. K. Barlowe and D. R. Appling, “Molecular genetic analysis of Saccharomyces cerevisiae C1-tetrahydrofolate synthase mutants reveals a noncatalytic function of the ADE3 gene product and an additional folate-dependent enzyme,” Molecular and Cellular Biology, vol. 10, no. 11, pp. 5679–5687, 1990. View at Google Scholar · View at Scopus
  19. A. Ulvik and P. M. Ueland, “Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism,” Clinical Chemistry, vol. 47, pp. 2050–2053, 2001. View at Google Scholar
  20. M. Fenech, “Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDAs),” Food and Chemical Toxicology, vol. 40, no. 8, pp. 1113–1117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. D. Williams and M. K. Jacobson, “Photobiological implications of folate depletion and repletion in cultured human keratinocytes,” Journal of Photochemistry and Photobiology B: Biology, vol. 99, no. 1, pp. 49–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. G. Linhart, A. Troen, G. W. Bell et al., “Folate deficiency induces genomic uracil misincorporation and hypomethylation but does not increase DNA point mutations,” Gastroenterology, vol. 136, no. 1, pp. 227.e3–235.e3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Fenech, M. Kirsch-Volders, A. T. Natarajan et al., “Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells,” Mutagenesis, vol. 26, no. 1, pp. 125–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Chang, T. Zhang, Z. Zhang et al., “Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects,” Journal of Nutritional Biochemistry, vol. 22, no. 12, pp. 1172–1177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. A. Hobbs, S. L. Sherman, P. Yi et al., “Polymorphisms in genes involved in folate metabolism as maternal risk factors for down syndrome,” The American Journal of Human Genetics, vol. 67, no. 3, pp. 623–630, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. V. B. O'Leary, A. Parle-McDermott, A. M. Molloy et al., “MTRR and MTHFR polymorphism: Link to Down syndrome?” American Journal of Medical Genetics, vol. 107, no. 2, pp. 151–155, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Chango, N. Fillon-Emery, C. Mircher et al., “No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers,” British Journal of Nutrition, vol. 94, no. 2, pp. 166–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. L. R. J. da Silva, N. Vergani, L. D. C. Galdieri et al., “Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in Brazil,” The American Journal of Medical Genetics, vol. 135, no. 3, pp. 263–267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Scala, B. Granese, M. Sellitto et al., “Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring,” Genetics in Medicine, vol. 8, no. 7, pp. 409–416, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. S. S. Wang, F. Y. Qiao, L. Feng, and J. J. Lv, “Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome in China,” Journal of Zhejiang University: Science B, vol. 9, no. 2, pp. 93–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. C. B. Santos-Rebouças, J. C. Corrêa, A. Bonomo et al., “The impact of folate pathway polymorphisms combined to nutritional deficiency as a maternal predisposition factor for Down syndrome,” Disease Markers, vol. 25, no. 3, pp. 149–157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. C. M. Ribeiro, “Análise dos polimorfismos MTHFD-1 1958G>A, TCII 776 C>G, MTR 2756A>G, MTRR 66A>G, RFC-1 80G>A e SHMT-1 1420C>T como fatores genéticos de risco para síndrome de Down,” 2008, http://www.bibliotecadigital.unicamp.br/document/?code=000437626.
  33. N. Fintelman-Rodrigues, J. C. Corrêa, J. M. Santos, M. M. G. Pimentel, and C. B. Santos-Rebouças, “Investigation of CBS, MTR, RFC-1 and TC polymorphisms as maternal risk factors for Down syndrome,” Disease Markers, vol. 26, no. 4, pp. 155–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. C. C. Urpia, “Estudo dos polimorfismos 677C>T e 1298A>C no gene da metilenotetrahidrofolato redutase e 66A>G no gene da metionina sintase redutase e a relação com a ocorrência da síndrome de down,” 2009, http://www.dominiopublico.gov.br/pesquisa/DetalheObraForm.do?select_action=&co_obra=171280.
  35. E. Pozzi, P. Vergani, L. Dalpra et al., “Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome,” The American Journal of Obstetrics and Gynecology, vol. 200, no. 6, pp. 636.e1–636.e6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Coppedè, F. Migheli, S. Bargagna et al., “Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring,” Neuroscience Letters, vol. 449, no. 1, pp. 15–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. A. P. C. Brandalize, E. Bandinelli, P. A. D. Santos, and L. Schüler-Faccini, “Maternal gene polymorphisms involved in folate metabolism as risk factors for Down syndrome offspring in Southern Brazil,” Disease Markers, vol. 29, no. 2, pp. 95–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Neagos, R. Cretu, A. Tutulan-Cunita, V. Stoian, and L. C. Bohiltea, “Methylenetetrahydrofolate dehydrogenase (MTHFD) enzyme polymorphism as a maternal risk factor for trisomy 21: a clinical study,” Journal of Medicine and Life, vol. 3, no. 4, pp. 454–457, 2010. View at Google Scholar · View at Scopus
  39. B. L. Zampieri, J. M. Biselli, E. M. Goloni-Bertollo et al., “Maternal risk for down syndrome is modulated by genes involved in folate metabolism,” Disease Markers, vol. 32, no. 2, pp. 73–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Coppedè, P. Bosco, V. Lorenzoni et al., “The MTR 2756A>G polymorphism and maternal risk of birth of a child with Down syndrome: a case-control study and a meta-analysis,” Molecular Biology Reports, vol. 40, no. 12, pp. 6913–6925, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. P. Liao, D. Zhang, W. Zhou et al., “Combined folate gene MTHFD and TC polymorphisms as maternal risk factors for Down syndrome in China,” Genetics and Molecular Research, vol. 13, no. 1, pp. 1764–1773, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Mantel and W. Haenszel, “Statistical aspects of the analysis of data from retrospective studies of disease,” Journal of the National Cancer Institute, vol. 22, no. 4, pp. 719–748, 1959. View at Google Scholar
  43. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Publisher · View at Google Scholar · View at Scopus
  44. W. G. Cochran, “The combination of estimates from different experiments,” Biometrics, vol. 10, pp. 101–129, 1954. View at Google Scholar
  45. J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088–1101, 1994. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  47. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. J. D. Finkelstein and J. J. Martin, “Homocysteine,” The International Journal of Biochemistry & Cell Biology, vol. 32, no. 4, pp. 385–389, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. J. J. Issa, “DNA methylation and cancer,” Critical Reviews in Oncology/Hematology, vol. 32, pp. 31–43, 1999. View at Publisher · View at Google Scholar
  50. J. Lewis and A. Bird, “DNA methylation and chromatin structure,” FEBS Letters, vol. 285, no. 2, pp. 155–159, 1991. View at Publisher · View at Google Scholar · View at Scopus
  51. G. R. Wasson, A. P. McGlynn, H. McNulty et al., “Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation,” Journal of Nutrition, vol. 136, no. 11, pp. 2748–2753, 2006. View at Google Scholar · View at Scopus
  52. M. Pufulete, R. Al-Ghnaniem, J. A. Rennie et al., “Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer,” British Journal of Cancer, vol. 92, no. 5, pp. 838–842, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. G. C. Rampersaud, G. P. A. Kauwell, A. D. Hutson, J. J. Cerda, and L. B. Bailey, “Genomic DNA methylation decreases in response to moderate folate depletion in elderly women,” The American Journal of Clinical Nutrition, vol. 72, no. 4, pp. 998–1003, 2000. View at Google Scholar · View at Scopus
  54. R. A. Jacob, D. M. Gretz, P. C. Taylor et al., “Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women,” Journal of Nutrition, vol. 128, no. 7, pp. 1204–1212, 1998. View at Google Scholar · View at Scopus
  55. S. A. Lamprecht and M. Lipkin, “Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms,” Nature Reviews Cancer, vol. 3, no. 8, pp. 601–614, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Beetstra, P. Thomas, C. Salisbury, J. Turner, and M. Fenech, “Folic acid deficiency increases chromosomal instability, chromosome 21 aneuploidy and sensitivity to radiation-induced micronuclei,” Mutation Research, vol. 578, no. 1-2, pp. 317–326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Wang, P. Thomas, J. Xue, and M. Fenech, “Folate deficiency induces aneuploidy in human lymphocytes in vitro—evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 551, no. 1-2, pp. 167–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. R. A. Martienssen and E. J. Richards, “DNA methylation in eukaryotes,” Current Opinion in Genetics and Development, vol. 5, no. 2, pp. 234–242, 1995. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Antequera, D. Macleod, and A. P. Bird, “Specific protection of methylated CpGs in mammalian nuclei,” Cell, vol. 58, no. 3, pp. 509–517, 1989. View at Publisher · View at Google Scholar · View at Scopus
  60. C. A. Hobbs, M. A. Cleves, R. M. Lauer, T. L. Burns, and S. J. James, “Preferential transmission of the MTHFR 677 T allele to infants with Down syndrome: implications for a survival advantage,” American Journal of Medical Genetics, vol. 113, no. 1, pp. 9–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. B. C. Blount, M. M. Mack, C. M. Wehr et al., “Medical Sciences Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3290–3295, 1997. View at Publisher · View at Google Scholar · View at Scopus
  62. M. R. Munafò and J. Flint, “Meta-analysis of genetic association studies,” Trends in Genetics, vol. 20, no. 9, pp. 439–444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. S. J. James, “Maternal metabolic phenotype and risk of Down syndrome: beyond genetics,” The American Journal of Medical Genetics, vol. 127, no. 1, pp. 1–4, 2004. View at Google Scholar · View at Scopus
  64. J. P. Ioannidis, N. A. Patsopoulos, and E. Evangelou, “Uncertainty in heterogeneity estimates in meta-analyses,” British Medical Journal, vol. 335, no. 7626, pp. 914–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Hemminki, J. L. Bermejo, and A. Försti, “The balance between heritable and environmental aetiology of human disease,” Nature Reviews Genetics, vol. 7, no. 12, pp. 958–965, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. J. A. C. Sterne, R. M. Harbord, and J. P. T. Higgins, “Meta-regression in Stata,” in Meta-Analysis in Stata: An Updated Collection from the Stata Journal, J. A. C. Sterne, Ed., pp. 70–96, Stata Press, College Station, Tex, USA, 2009. View at Google Scholar
  67. S. G. Thompson and J. P. T. Higgins, “How should meta-regression analyses be undertaken and interpreted?” Statistics in Medicine, vol. 21, no. 11, pp. 1559–1574, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Bosco, R. M. Guéant-Rodriguez, G. Anello et al., “Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome,” The American Journal of Medical Genetics A, vol. 121, no. 3, pp. 219–224, 2003. View at Google Scholar
  69. M.-L. Martínez-Frías, B. Pérez, L. R. Desviat et al., “Maternal polymorphisms 677C-T and 1298A-C of MTHFR, and 66A-G MTRR geness: is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome?” The American Journal of Medical Genetics, vol. 140, no. 9, pp. 987–997, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. P. de Marco, E. Merello, M. G. Calevo et al., “Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk,” Journal of Human Genetics, vol. 51, no. 2, pp. 98–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Parle-McDermott, F. Pangilinan, J. L. Mills et al., “A polymorphism in the MTHFD1 gene increases a mother's risk of having an unexplained second trimester pregnancy loss,” Molecular Human Reproduction, vol. 11, no. 7, pp. 477–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Yang, T. Gong, X. Lin et al., “Maternal gene polymorphisms involved in folate metabolism and the risk of having a down syndrome offspring: a meta-analysis,” Mutagenesis, vol. 28, no. 6, pp. 661–671, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. M. R. Amorim and M. A. C. Lima, “MTRR 66A>G polymorphism as maternal risk factor for Down syndrome: a meta-analysis,” Genetic Testing and Molecular Biomarkers, vol. 17, no. 1, pp. 69–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. D. Hu, X. Lin, H. Zhang, X. Zheng, and W. Niu, “APEX nuclease (multifunctional DNA repair enzyme) 1 gene Asp148Glu polymorphism and cancer risk: a meta-analysis involving 58 articles and 48903 participants,” PLoS ONE, vol. 8, no. 12, Article ID e83527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. S. M. Naushad, A. Prayaga, R. R. Digumarti, S. R. Gottumukkala, and V. K. Kutala, “Bcl-2/adenovirus E1B 19 kDa-interacting protein 3 (BNIP3) expression is epigenetically regulated by one-carbon metabolism in invasive duct cell carcinoma of breast,” Molecular and Cellular Biochemistry, vol. 361, no. 1-2, pp. 189–195, 2012. View at Publisher · View at Google Scholar · View at Scopus